Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System

Inclusion Criteria: Subjects must meet all of the following criteria to be eligible for enrollment in this study: 1. Male or female subjects aged ≥40 and ≤95 years. 2. Subjects admitted with vertebral compression fractures (VCFs) caused by osteoporosis or trauma. 3. Surgical site within the range of T6 to L5. 4. Subjects with normal vital signs and hepatic and renal function values within 1.5 times the upper limit of normal (ULN), as determined by the investigator to be suitable for study participation. 5. Subjects willing to comply with the study schedule and all required assessment procedures. 6. Subjects who are conscious, cognitively intact, and able to provide written informed consent. Exclusion Criteria: Subjects who meet any of the following criteria will be excluded from participation in this study: 1. Pathological fractures caused by bone diseases, including benign or malignant tumors, tuberculosis, osteomyelitis, endocrine or metabolic bone disorders, or severe degenerative bone diseases. 2. Active or severe systemic infections. 3. Metabolic disorders (e.g., calcium metabolism disorders), immune system disorders, substance abuse, or alcoholism. 4. Severe primary diseases involving the hematopoietic or endocrine systems, or psychiatric disorders. 5. History of allergy to implant materials, hypersensitivity reactions, or allergies to multiple medications. 6. Non-viable bone surrounding the surgical site or insufficient bone quality to support the implant. 7. Active infection at or adjacent to the surgical site. 8. Acute spinal instability. 9. Unwillingness or inability to restrict physical activity or comply with medical instructions. 10. Considered unsuitable for study participation by the investigator, or unable to provide independent informed consent.